Related Experiment Video
Updated: Aug 9, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Is asthma research in dead end?
Annette Amon1, Andreas Pahl, Istvan Szelenyi
1Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen, Fahrstr. 17, 91054 Erlangen, Germany.
Summary
New asthma treatments are urgently needed as single-target drugs are ineffective. Future research should focus on novel, multi-action therapies and serendipity-based drug discovery for better asthma management.
Area of Science:
- Pulmonology
- Pharmacology
- Drug Discovery
Background:
- Bronchial asthma remains a significant global health issue despite therapeutic advancements.
- Current understanding of asthma pathogenesis has grown, yet effective treatments are still lacking.
- Existing therapies often target single mediators, proving insufficient for comprehensive asthma control.
Purpose of the Study:
- To highlight the limitations of current asthma treatment strategies.
- To advocate for the development of novel therapeutic approaches for bronchial asthma.
- To propose a shift in drug screening methodologies towards more innovative research.
Main Methods:
- Review of current therapeutic strategies for bronchial asthma.
- Analysis of the efficacy of single-mediator targeted drugs.
- Discussion on the potential of multi-action drugs and serendipity-based research.
Main Results:
- The single mediator approach has shown limited success in asthma treatment.
- Drugs with multiple sites of action present a more promising therapeutic avenue.
- Current drug screening strategies may require re-evaluation.
Conclusions:
- There is a critical need for new and more effective treatments for bronchial asthma.
- Multi-target drugs offer greater potential for successful therapeutic introduction.
- A move towards serendipity-based research could accelerate the discovery of novel asthma therapies.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: